Patent · US Active

Influenza virus replication inhibitor and use thereof

US11104689B2 · kind B2 · utility

0Cited by
11References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2018
Grant dateAug 31, 2021
Priority date
Expiry dateSep 18, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.